°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (85,500¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (63,000¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (72,000¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

Brody's Human Pharmacology : Mechanism-Based Therapeutics

ÇÑÁ¤ÆǸŠ¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

°øÀ¯Çϱâ
  • ÃâÆÇ»ç : Elsevier
  • ¹ßÇà : 2018³â 07¿ù 24ÀÏ
  • Âʼö : 728
  • ISBN : 9780323476522
Á¤°¡

90,000¿ø

  • 90,000¿ø

    2,700P (3%Àû¸³)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
  • 4/20(Åä) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
  • ÁÖ¹®¼ö·®
    °¨¼Ò Áõ°¡
    • À̺¥Æ®/±âȹÀü

    • ¿¬°üµµ¼­

    • »óÇ°±Ç

    AD

    ¸ñÂ÷

    Section 1 Mechanisms of Drug Action and Therapeutic Principles

    1. Introduction, Terminology

    2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc)

    3. Pharmacokinetics

    4. Pharmacogenomics

    5. Drug Discovery, Development, and Regulation

    Section 2 Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses

    6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders

    Cholinergic Drugs

    7. Muscarinic Agonists and Their Clinical Uses

    8. Muscarinic Antagonists and Their Clinical Uses

    9. Nicotinic Agonists and Their Clinical Uses

    10. Nicotinic Antagonists and Neuromuscular Blocking Drugs

    Adrenergic Drugs

    11. Adrenergic Agonists and Their Clinical Uses

    12. Adrenergic Antagonists and Their Clinical Uses

    Section 3 Drug Treatment for Disorders Affecting the Central Nervous System

    13. Introduction to the CNS and Drugs Affecting the Brain

    Neurodegenerative Disorders

    14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders/Dementias

    15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease

    16. Drug Therapy for Psychoses and Bipolar Disorder

    17. Drug Therapy for Depression and Anxiety

    18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder

    19. Drug Therapy for Insomnia and the Hypersomnias

    20. Drug Therapy for Managing Obesity and Eating Disorders

    21. Treatment of Seizure Disorders

    22. Drug Therapy to Control Spasticity Disorders

    23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder

    24. Illicit Psychoactive Compounds and Substance Use Disorder

    Section 4 Drug Therapy for Pain Management

    25. Introduction

    26. General Anesthetics

    27. Local Anesthetics

    28. Opioid Analgesics

    29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen

    30. Cannabinoids

    Section 5 Treatment of Inflammatory, Allergic and Immunologic Disorders

    31. Drug Therapy for Migraine Headache

    32. Drug Therapy for Gout and Hyperuricemia

    33. Drug Treatment for Allergic Reactions

    34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation

    35. Drug Therapy for Rheumatoid Arthritis

    Section 6 Drug Treatment for Cardiovascular Diseases

    36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate

    37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone

    38. Diuretics and Drugs that Affect Volume and Electrolyte Content

    39. Drugs Affecting the Renin-Angiotensin-Aldosterone System

    40. Calcium Channel Blockers

    41. Vasodilators

    42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease

    43. Drug Therapy for Myocardial Ischemia and Angina Pectoris

    44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents

    45. Antiarrhythmic Drugs

    46. Anticoagulant, Antiplatelet and Thrombolytic Agents

    47. Drug Therapy for Hemophilia and the Anemias

    Section 7 Treatment of Endocrine Disorders

    48. Introduction to Endocrine Pharmacology

    49. Treatment of Hypothalamic and Pituitary Disorders

    50. Treatment of Adrenalcorticosteroid Disorders

    51. Female Hormone Regulation

    52. Androgens, antiandrogens and their clinical uses

    53. Drug Therapy for the Management of Diabetes

    54. Drug Therapy for the Management of Thyroid Disorders

    55. Calcium Regulating Hormones and Agents Affecting Bone

    Section 8 Chemotherapy

    Infectious Diseases

    56. Principles of Antimicrobial Use

    57. Bacterial Cell Wall Synthesis Inhibitors

    58. Inhibitors of Protein Synthesis

    59. Drugs that Target DNA

    60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy

    61. Drug Therapy for Resistant Organisms

    Parasitic Diseases

    62. Antifungal Agents

    63. Antimalarial and Other Antiprotozoal Agents

    64. Antihelmintics

    Viruses

    65. Drug Therapy for non-HIV Viral Infections

    66. Drugs for HIV and Related Opportunistic Infections

    Cancer

    67. Introduction and Therapeutic Principles

    68. Cytotoxic Agents

    69. Targeted Agents

    Section 9 Special Considerations

    70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals

    71. Gastrointestinal Disorders and Their Treatment

    72. Pharmacological Treatment of Asthma and COPD

    73. The Role of Neutraceuticals and Natural Products

    74. Essentials of Toxicology

    75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals

    Ã¥¼Ò°³

    Focusing on the essential aspects of pharmacology you need to know, Brody¡®s Human Pharmacology, 6th Edition, keeps you fully up to date with all that¡¯s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information.

    The 6th Edition of this easy-to-use text is now fully up to date with:

    NEW chapter devoted entirely to pharmacogenomics and personalized medicine.
    NEW chapter on cannabinoids and their use for pain and other disorders, in light of recent legalization in many states.
    NEW chapters on recent developments in the treatment of Alzheimer's disease, ADHD and the latest treatments for HIV.
    NEW section on pain management.
    NEW?section in each chapter covering "Clinical Relevance for Healthcare Professionals" that provides important information specific to physical therapists, dentists and dental hygienists, and many other medical professionals.

    Plus these student-friendly features:

    A new organizational approach, focusing on integration and systems-based learning.
    Contributions from leading faculty who cover the most important aspects of pharmacology necessary for a basic understanding of the subject, including concepts, clinical applications, and side effects.
    USMLE-style self-assessment questions at the end of every chapter, answers and rationales in the Appendix.
    Online access to Student Consult¡ªwhere you¡¯ll find the complete contents of the book, fully searchable...150 USMLE-style questions...and more.

    ´ëÇб³Àç/Àü¹®¼­Àû ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

      ¸®ºä

      0.0 (ÃÑ 0°Ç)

      100ÀÚÆò

      ÀÛ¼º½Ã À¯ÀÇ»çÇ×

      ÆòÁ¡
      0/100ÀÚ
      µî·ÏÇϱâ

      100ÀÚÆò

      10.0
      (ÃÑ 0°Ç)

      ÆǸÅÀÚÁ¤º¸

      • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

      »óÈ£

      (ÁÖ)±³º¸¹®°í

      ´ëÇ¥ÀÚ¸í

      ¾Èº´Çö

      »ç¾÷ÀÚµî·Ï¹øÈ£

      102-81-11670

      ¿¬¶ôó

      1544-1900

      ÀüÀÚ¿ìÆíÁÖ¼Ò

      callcenter@kyobobook.co.kr

      Åë½ÅÆǸž÷½Å°í¹øÈ£

      01-0653

      ¿µ¾÷¼ÒÀçÁö

      ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

      ±³È¯/ȯºÒ

      ¹ÝÇ°/±³È¯ ¹æ¹ý

      ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

      ¹ÝÇ°/±³È¯°¡´É ±â°£

      º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
      ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

      ¹ÝÇ°/±³È¯ ºñ¿ë

      º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
      »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

      ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

      ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
      (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

      ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
      ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

      ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
      ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

      ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

      ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

      »óÇ° Ç°Àý

      °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

      ¼ÒºñÀÚ ÇÇÇغ¸»ó
      ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

      ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

      ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

      (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

      (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
      (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

      ¹è¼Û¾È³»

      • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

      • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

      • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

      • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

      • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë